LivaNova PLC (LIVN) Holdings Increased by American Century Companies Inc.

American Century Companies Inc. boosted its position in LivaNova PLC (NASDAQ:LIVN) by 11.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 436,478 shares of the company’s stock after purchasing an additional 45,379 shares during the quarter. American Century Companies Inc. owned about 0.91% of LivaNova worth $34,883,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. PNC Financial Services Group Inc. raised its position in shares of LivaNova by 9.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after buying an additional 153 shares in the last quarter. Strs Ohio raised its position in shares of LivaNova by 2.9% during the 4th quarter. Strs Ohio now owns 21,100 shares of the company’s stock valued at $1,686,000 after buying an additional 600 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of LivaNova by 9.7% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,274 shares of the company’s stock valued at $578,000 after buying an additional 643 shares in the last quarter. Rhumbline Advisers raised its position in shares of LivaNova by 1.3% during the 3rd quarter. Rhumbline Advisers now owns 94,714 shares of the company’s stock valued at $6,636,000 after buying an additional 1,189 shares in the last quarter. Finally, Aperio Group LLC raised its position in shares of LivaNova by 21.4% during the 4th quarter. Aperio Group LLC now owns 6,810 shares of the company’s stock valued at $544,000 after buying an additional 1,200 shares in the last quarter. Institutional investors and hedge funds own 88.53% of the company’s stock.

Several analysts have recently weighed in on LIVN shares. Piper Jaffray Companies restated a “buy” rating and set a $85.00 price objective on shares of LivaNova in a research report on Friday, November 3rd. Jefferies Group raised their price objective on shares of LivaNova from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Friday, November 3rd. Needham & Company LLC raised their price objective on shares of LivaNova from $83.00 to $89.00 and gave the company a “buy” rating in a research report on Friday, November 3rd. ValuEngine upgraded shares of LivaNova from a “hold” rating to a “buy” rating in a research report on Thursday, November 2nd. Finally, Zacks Investment Research upgraded shares of LivaNova from a “hold” rating to a “buy” rating and set a $89.00 price objective on the stock in a research report on Thursday, November 9th. Two analysts have rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $79.71.

In related news, Director Hugh M. Morrison sold 1,830 shares of LivaNova stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $88.00, for a total value of $161,040.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Daniel Jeffrey Moore sold 1,000 shares of LivaNova stock in a transaction on Friday, December 15th. The stock was sold at an average price of $80.80, for a total transaction of $80,800.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 5,830 shares of company stock worth $495,530. 0.28% of the stock is owned by corporate insiders.

LivaNova PLC (LIVN) opened at $81.76 on Wednesday. The company has a market cap of $3,967.81, a price-to-earnings ratio of 69.88, a P/E/G ratio of 2.44 and a beta of 0.83. LivaNova PLC has a 52-week low of $46.34 and a 52-week high of $88.56. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.03 and a quick ratio of 1.42.

COPYRIGHT VIOLATION WARNING: “LivaNova PLC (LIVN) Holdings Increased by American Century Companies Inc.” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/14/livanova-plc-livn-holdings-increased-by-american-century-companies-inc.html.

About LivaNova

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Institutional Ownership by Quarter for LivaNova (NASDAQ:LIVN)

Receive News & Ratings for LivaNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply